DS-2330

CAS No. 1634680-81-1

DS-2330( DS2330 | DS-2330b )

Catalog No. M12462 CAS No. 1634680-81-1

DS-2330 is a phosphorous lowering agent for treating hyperphosphatemia in chronic kidney disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DS-2330
  • Note
    Research use only, not for human use.
  • Brief Description
    DS-2330 is a phosphorous lowering agent for treating hyperphosphatemia in chronic kidney disease.
  • Description
    DS-2330 is a phosphorous lowering agent for treating hyperphosphatemia in chronic kidney disease.Other Indication Phase 1 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DS2330 | DS-2330b
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    1634680-81-1
  • Formula Weight
    780.937
  • Molecular Formula
    C43H48N4O8S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    4-(4-(2-(3-(N-((1r,4r)-4-carboxycyclohexyl)-N-ethylsulfamoyl)benzamido)-5-(piperidin-1-yl)benzamido)phenethyl)benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • α-Melanocyte Stimula...

    α-Melanocyte Stimulating Hormone [Acetyl-D-Lys11, D-Val13] (11-13) (MSHa)

  • [Tyr0] Gastric Inhib...

    [Tyr0] Gastric Inhibitory Peptide (23-42), human; [Tyr22] Gastric Inhibitory Peptide (22-42), human

  • SM-102

    SM-102 is an ionizable amino lipid that can be used for the formation of lipid nanoparticles (LNPs). SM-102 has the potential for development of lipid nanoparticles for delivery of mRNA-based vaccines.